Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$11.01
-0.640 (-5.49%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $10.48 $12.11 Thursday, 9th May 2024 DVAX stock ended at $11.01. This is 5.49% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 6.49% from a day low at $10.48 to a day high of $11.16.
90 days $10.48 $13.27
52 weeks $10.48 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Dec 15, 2022 $11.41 $11.58 $10.99 $11.15 2 126 917
Dec 14, 2022 $11.24 $11.70 $11.24 $11.55 1 550 391
Dec 13, 2022 $11.50 $11.82 $11.45 $11.61 1 902 265
Dec 12, 2022 $11.25 $11.54 $11.11 $11.22 2 171 744
Dec 09, 2022 $11.57 $11.63 $11.23 $11.25 1 456 941
Dec 08, 2022 $11.57 $11.73 $11.31 $11.63 1 389 083
Dec 07, 2022 $11.53 $11.74 $11.32 $11.53 4 009 886
Dec 06, 2022 $12.23 $12.44 $11.20 $11.61 6 573 112
Dec 05, 2022 $12.65 $12.70 $12.04 $12.30 1 368 721
Dec 02, 2022 $12.37 $12.80 $12.29 $12.72 1 216 519
Dec 01, 2022 $12.37 $12.67 $12.28 $12.54 1 215 913
Nov 30, 2022 $11.94 $12.42 $11.89 $12.41 1 718 639
Nov 29, 2022 $12.01 $12.04 $11.70 $11.88 1 000 100
Nov 28, 2022 $12.25 $12.47 $11.87 $11.93 1 799 118
Nov 25, 2022 $12.45 $12.61 $12.31 $12.34 502 675
Nov 23, 2022 $12.78 $12.92 $12.59 $12.63 819 182
Nov 22, 2022 $12.91 $12.91 $12.53 $12.82 1 444 355
Nov 21, 2022 $12.78 $12.93 $12.68 $12.73 681 117
Nov 18, 2022 $13.50 $13.50 $12.96 $12.96 802 335
Nov 17, 2022 $12.77 $13.28 $12.63 $13.07 629 248
Nov 16, 2022 $13.06 $13.30 $12.92 $12.94 654 508
Nov 15, 2022 $13.10 $13.37 $12.87 $13.23 1 044 030
Nov 14, 2022 $12.76 $13.18 $12.70 $13.01 890 413
Nov 11, 2022 $12.71 $12.94 $12.23 $12.84 2 245 600
Nov 10, 2022 $12.45 $12.98 $12.33 $12.90 2 005 640
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT